X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-09-06 | CDIO | Dogan Timur | CTO | P - Purchase | $0.29 | +68,965 | 197,310 | +54% | +$20,000 | |||||
| A | 2024-09-06 | CDIO | Dogan Meeshanthini | CEO | P - Purchase | $0.29 | +68,965 | 1,655,429 | +4% | +$20,000 | |||||
| A | 2024-09-06 | NUTX | Dogan Meeshanthini | CEO | P - Purchase | $0.29 | +68,965 | 1,655,429 | +4% | +$20,000 | |||||
| A | 2024-09-06 | NUTX | Dogan Timur | CTO | P - Purchase | $0.29 | +68,965 | 197,310 | +54% | +$20,000 | |||||
2024-09-06 | CDIO | Philibert Robert | Chief Medical Officer | P - Purchase | $0.29 | +34,075 | 1,683,867 | +2% | +$9,763 | ||||||
2024-09-06 | CDIO | Dogan Meeshanthini | CTO | P - Purchase | $0.29 | +68,965 | 197,310 | +54% | +$20,000 | ||||||
2024-09-06 | CDIO | Dogan Meeshanthini | CEO | P - Purchase | $0.29 | +68,965 | 1,683,867 | +4% | +$20,000 | ||||||
| M | 2023-08-25 | CDIO | Dogan Meeshanthini | CEO, 10% | P - Purchase | $0.55 | +18,251 | 128,345 | +17% | +$9,964 | |||||
| M | 2023-08-25 | CDIO | Dogan Timur | CTO | P - Purchase | $0.55 | +18,251 | 128,345 | +17% | +$9,964 | |||||
| M | 2023-08-24 | CDIO | Philibert Robert | Chief Medical Officer, 10% | P - Purchase | $0.60 | +34,000 | 3,281,584 | +1% | +$20,395 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |